Litigation Details for Ravgen, Inc. v. Natera, Inc. (W.D. Tex. 2020)
✉ Email this page to a colleague
Ravgen, Inc. v. Natera, Inc. (W.D. Tex. 2020)
| Docket | ⤷ Try a Trial | Date Filed | 2020-06-01 |
| Court | District Court, W.D. Texas | Date Terminated | 2020-06-30 |
| Cause | 35:271 Patent Infringement | Assigned To | Alan D. Albright |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 7,727,720 | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Ravgen, Inc. v. Natera, Inc.
The biologic drugs covered by the patent cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Ravgen, Inc. v. Natera, Inc. (W.D. Tex. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-06-01 | 1 | Complaint | United States Patent Nos. 7,727,720 (the “’720 Patent”) and 7,332,277 (the “’277 Patent”) (collectively…collectively the “Patents-in-Suit”), arising under the Patent Laws of the United States, 35 U.S.C. §§ 271, et…resulted in the issuance of several patents, including the Patents-in-Suit. Case 6:20-cv-00451…United States Patent and Trademark Office on February 19, 2008. The inventor of the patent is Ravinder …Ravinder S. Dhallan, and the patent is assigned to Ravgen. A copy of the ’277 Patent is attached hereto as Exhibit | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
